Quetiapine in the treatment of Tic disorder [3]

Annals of Pharmacotherapy

Volumn 40, Issue 7-8, 2006, Pages 1472-

  Little, Allison E ^a   Augustin, Sara G ^b   Kissack, Julie C ^c  

^a ATLANTA MEDICAL CENTER   (United States)

^b Department of Pharmacy   (United States)

^c MERCER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; ESCITALOPRAM; OLANZAPINE; QUETIAPINE; VALPROIC ACID;

ADULT; AGITATION; ANXIETY; BIPOLAR II DISORDER; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; INVOLUNTARY MOVEMENT; LETTER; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; TIC; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; HUMANS; MALE; TIC DISORDERS;

EID: 33747020534     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G596     Document Type: Letter

References (5)

1. Singer HS. Tourette's syndrome: from behaviour to biology. Lancet Neurol 2005;4:149-59.
2. Kastrup A, Schlotter W, Plewnia C, Bartels M. Treatment of tics in Tourette syndrome with aripiprazole (letter). J Clin Psychopharmacol 2005;25:94-6.
3. Parraga HC, Woodward RL. Quetiapine for Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 2001;40:389-91.
4. Barzman D, Gernert B, Delbello M. Quetiapine for chronic motor tic disorder. Am J Psychiatry 2004;161:1307.
5. Richelson E. Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry 1999;60(suppl 10):5-14.